PATENT CLAIM ANALYSIS

Application Number: 15925929
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-07
Patent Classification: ["435", "287100"]

Abstract:
A device is disclosed for conducting a non-invasive analysis of a bodily fluid to determine the presence and level of a certain constituent carried by the bodily fluid. An indicator formulation of the device changes color in response to exposure to the constituent to provide a visible indication of the presence and level of the constituent carried by the bodily fluid. A carrier substrate of the device is constructed of a material having voids providing a high void volume within the substrate. The device is made by applying a chromagen to the carrier substrate to create a chromagen-laden carrier member. Then, a selected reagent having a particular constituent-specific formulation is applied to the chromagen-laden member. The selected reagent then combines with the chromagen thereby establishing the indicator formulation within the carrier substrate in place for reception of a sample of the bodily fluid.

Claim (Index 3):
The device of  claim 2  including:\n a target area for the reception of a single sample of the bodily fluid, the treatment pad being juxtaposed with the target area and interposed between the target area and the second test pad; \n the target area being juxtaposed with the first test pad in direct communication with the first test pad, and being juxtaposed with the treatment pad in direct communication with the treatment pad, such that upon applying the single sample to the target area, a first portion of the single sample will enter the first test pad to provide the visible indication of the presence and level of cholesterol carried by the bodily fluid, while a second portion of the single sample will pass through the treatment pad wherein the low density lipoid fractions will be removed prior to the second portion of the single sample entering the second test pad to provide the visible indication of the presence and level of high density lipoid fractions of cholesterol in the bodily fluid, thereby enabling the calculation to determine the presence and level of low density lipoid fractions present in the bodily fluid.

Metadata:
- Claim Count in Document: 7.0
- Percentile: 90.0
- Lexical Diversity: 2.23881
- Patent Class: 435.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15155803', '15388697', '15481782', '14684861', '13606299']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6619250604030209
- 35 USC 102 Novelty (BERT): 0.544189826035506
- Combined Prediction Score: 0.6501515369662695
- Mean Citation Score: 390.661478
- Max Citation Score: 432.2445
- Similarity Product: 267.70610361626746

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test